Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Andreatta M, Karosiene E, Rasmussen M, Stryhn A, Buus S, Nielsen M
Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide is non-inferior to once-daily liraglutide and superior to placebo in Japanese patients with type 2 diabetes: a 26-week randomized phase III study
Research peptide suppliers offer lower prices but with significant quality and legal risks
Authors' contributions PJ was responsible for study design, data collection, statistical analysis, and manuscript preparation
US$ 23.26
![Winona Reviews [2026]](https://innerbody.imgix.net/winona-review-lineup.jpg?auto=format,compress&fit=max&w=826&q=75)
US$ 24.08
US$ 23.62
